ISSN 0303-5212
 
2024, Vol: 49, Issue: 1
49 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author_ Certificate.docx
Bank Reciept

Original Research 
RMJ. 2019; 44(1): 137-140


Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor

Nighat Shaheen, Safia Khalil.

Abstract
Objective: To compare the safety and efficacy of Misoprostol with Oxytocin for management of third stage of labor.
Methodology: This randomized control trial was conducted at Department of Gynecology and Obstetrics, Cantonment General Hospital, Rawalpindi, Pakistan from May to Oct 2015. A total of 212 singleton pregnant women were selected. Women were allocated to either group using simple computer generated randomization table. Group I received 10 U intramuscular Oxytocin while group II received 600ug sublingual Misoprostol. Primary outcome measures were severity of primary postpartum hemorrhage, amount of blood loss and side effects of drugs.
Results: The mean blood loss was 303.50+225.35 in group I and 271.30+206.205 in group II (p=0.035). The average drop in hemoglobin was 0.84+0.78 in group I and 0.81+0.79 in group II (p=0.980). There is no association in two groups with regard to PPH, repeat dose, complications and blood transfusion (p=0.86).
Conclusion: Misoprostol was better than Oxytocin regarding average blood loss for the management of third stage of labor.

Key words: Misoprostol, Oxytocin, Prevention, Postpartum hemorrhage.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nighat Shaheen
Articles by Safia Khalil
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Shaheen N, Khalil S. Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. RMJ. 2019; 44(1): 137-140.

Web Style

Shaheen N, Khalil S. Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. https://www.rmj.org.pk/?mno=280413 [Access: December 06, 2023].

AMA (American Medical Association) Style

Shaheen N, Khalil S. Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. RMJ. 2019; 44(1): 137-140.


Vancouver/ICMJE Style

Shaheen N, Khalil S. Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. RMJ. (2019), [cited December 06, 2023]; 44(1): 137-140.


Harvard Style

Shaheen, N. & Khalil, . S. (2019) Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. RMJ, 44 (1), 137-140.


Turabian Style

Shaheen, Nighat, and Safia Khalil. 2019. Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. Rawal Medical Journal, 44 (1), 137-140.


Chicago Style

Shaheen, Nighat, and Safia Khalil. "Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor." Rawal Medical Journal 44 (2019), 137-140.


MLA (The Modern Language Association) Style

Shaheen, Nighat, and Safia Khalil. "Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor." Rawal Medical Journal 44.1 (2019), 137-140. Print.


APA (American Psychological Association) Style

Shaheen, N. & Khalil, . S. (2019) Safety and efficacy of 600 ug sublingual Misoprostol versus 10 U intramuscular Oxytocin for management of third stage of labor. Rawal Medical Journal, 44 (1), 137-140.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information